A Phase I Clinical Trial to Evaluate the Single Dose Ascending and Food Effects of PG-033 in Healthy Adults

Clinical trial NCT07013097 · RECRUITING

Trial details

NCT number: NCT07013097
Sponsor: Prime Gene Therapeutics Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Lichen Simplex Chronicus

Start date: 2025-05-23
Primary completion: 2026-12-31
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.